Surgery for Pediatric Cholesteatoma Workup

  • Author: Peter S Roland, MD; Chief Editor: Glenn C Isaacson, MD, FACS, FAAP   more...
 
Updated: Mar 25, 2010
 

Laboratory Studies

No laboratory diagnostic tests are generally necessary for cholesteatoma.

Next

Imaging Studies

  • Some surgeons believe that any patient with a cholesteatoma scheduled for surgical intervention should have a preoperative CT scan. These surgeons believe that useful information is obtained in every circumstance and, consequently, that the expense and radiation exposure is always justified. The imaging modality of choice is a fine-cut CT scan without intravenous contrast. CT scans can reveal the following subtle bony changes:
    • Scutal erosion
    • Labyrinthine fistula
    • Defects in the tegmen
    • Details of ossicular involvement
    • Details of ossicular erosion or discontinuity
    • Anomalies, erosion, or invasion of the facial nerve canalAn unenhanced CT scan demonstrating that the posteAn unenhanced CT scan demonstrating that the posterior canal wall has been eroded and the external auditory canal has filled with cholesteatoma, pus, and debris. Surprisingly, the middle ear appears relatively free of disease, a characteristic of primary acquired cholesteatomas.
  • CT scanning cannot always distinguish between granulation tissue and cholesteatoma.
    • Even technically excellent, fine-cut CT scans cannot always reveal the full extent of disease.
    • The surgeon, therefore, cannot always predict what will be encountered intraoperatively.
    • Both the operating surgeon and the patient must understand these limitations of the preoperative assessment and must prepare for intraoperative surprises.
  • Other surgeons reserve preoperative imaging for only special cases and are comfortable performing some operations without preoperative imaging. These surgeons are likely to request a preoperative CT scan in the following circumstances:
    • Doubtful diagnosis
      • The diagnosis may be in doubt.
      • CT scanning can distinguish between shallow retractions without soft tissue extension into the epitympanic space and an extensive soft tissue mass with bony erosion.
      • CT scanning may be helpful in individuals who already have had tympanomastoid surgery. In this group of patients, a white mass behind the TM can represent tympanosclerosis, cartilage deliberately placed at a previous operation, or recurrent cholesteatoma. CT scanning frequently helps determine which.
    • A patient who wishes to avoid surgery: Information from a CT scan may help a surgeon advise the patient and parents and/or caregivers that the presence of extensive disease, labyrinthine fistula, encroachment on the fallopian canal, and involvement of the oval window niche increase the risk of nonsurgical management.
    • If ossicular involvement is apparent on preoperative CT scans, then parents can be counseled that ossicular removal may be necessary and that a significant postoperative conductive hearing loss should be expected.
    • Indeterminate underlying anatomy and unclear extent of disease as the result of previous surgery
    • Reasonable expectation of congenital anomalies (eg, atresia, craniofacial anomalies)
    • Suspected complications
  • MRI is useful when the following very specific problems involving surrounding soft tissues are expected:
    • Dural involvement, invasion, and/or inflammation
    • Subdural or epidural abscess
    • The presence of herniated brain into the mastoid cavity
    • Inflammation of the membranous labyrinth or facial nerve
    • Intracranial invasion
    • Sigmoid sinus thrombosis
    • Meningitis
Previous
Next

Other Tests

  • Audiometry
    • In most circumstances, audiometry should be performed prior to surgery and should include air and bone conduction and speech discrimination testing.
    • Infrequently, a serious complication of cholesteatoma requires urgent surgery; in these patients, audiometric testing can be omitted.
Previous
Next

Histologic Findings

The histology of surgically removed cholesteatoma specimens demonstrates typical squamous epithelium. The histology is indistinguishable from sebaceous cysts or keratomas removed from any other portion of the body.

Previous
 
 
Contributor Information and Disclosures
Author

Peter S Roland, MD  Professor, Department of Neurological Surgery, Professor and Chairman, Department of Otolaryngology-Head and Neck Surgery, Director of Clinical Center for Auditory, Vestibular and Facial Nerve Disorders, Chief of Pediatric Otology, University of Texas Southwestern Medical Center; Adjunct Professor of Communicative Disorders, University of Texas School of Human Development

Peter S Roland, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American Laryngological Rhinological and Otological Society, American Neurotology Society, American Otological Society, North American Skull Base Society, and Society of University Otolaryngologists-Head and Neck Surgeons

Disclosure: Alcon Labs Honoraria Speaking and teaching; GSK Honoraria Speaking and teaching; Advanced Bionics Honoraria Board membership; Cochlear Corp Honoraria Board membership; Med El Corp travel grants Consulting

Specialty Editor Board

Orval Brown, MD  Director of Otolaryngology Clinic, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center at Dallas

Orval Brown, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics, American Bronchoesophagological Association, American College of Surgeons, American Medical Association, American Society of Pediatric Otolaryngology, Society for Ear, Nose and Throat Advances in Children, and Society of University Otolaryngologists-Head and Neck Surgeons

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Pharmacy Editor, eMedicine

Disclosure: Nothing to disclose.

John E McClay, MD  Associate Professor of Pediatric Otolaryngology, Department of Otolaryngology-Head and Neck Surgery, Children's Hospital of Dallas, University of Texas Southwestern Medical School

John E McClay, MD is a member of the following medical societies: American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, and American Medical Association

Disclosure: Nothing to disclose.

Paul D Petry, DO, FACOP, FAAP  Consulting Staff, Freeman Pediatric Care, Freeman Health System

Paul D Petry, DO, FACOP, FAAP is a member of the following medical societies: American Academy of Osteopathy, American Academy of Pediatrics, American College of Osteopathic Pediatricians, and American Osteopathic Association

Disclosure: Nothing to disclose.

Chief Editor

Glenn C Isaacson, MD, FACS, FAAP  Professor of Otolaryngology-Head and Neck Surgery and Pediatrics, Temple University School of Medicine

Glenn C Isaacson, MD, FACS, FAAP is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics, American Bronchoesophagological Association, American College of Surgeons, American Laryngological Rhinological and Otological Society, American Society of Pediatric Otolaryngology, and Society of University Otolaryngologists-Head and Neck Surgeons

Disclosure: Covidien Honoraria Consulting

References
  1. Roland PS, Meyerhoff WL. Open-cavity tympanomastoidectomy. Otolaryngol Clin North Am. Jun 1999;32(3):525-46. [Medline].

  2. Graham MD, Delap TG, Goldsmith MM. Closed tympanomastoidectomy. Otolaryngol Clin North Am. Jun 1999;32(3):547-54. [Medline].

  3. Manolidis S, Kutz JW Jr. Diagnosis and management of lateral sinus thrombosis. Otol Neurotol. Sep 2005;26(5):1045-51. [Medline].

  4. Kazahaya K, Potsic WP. Congenital cholesteatoma. Curr Opin Otolaryngol Head Neck Surg. Oct 2004;12(5):398-403. [Medline].

  5. Potsic WP, Korman SB, Samadi DS, Wetmore RF. Congenital cholesteatoma: 20 years' experience at The Children's Hospital of Philadelphia. Otolaryngol Head Neck Surg. Apr 2002;126(4):409-14. [Medline].

  6. Dawes PJ, Leaper M. Paediatric small cavity mastoid surgery: second look tympanotomy. Int J Pediatr Otorhinolaryngol. Feb 2004;68(2):143-8. [Medline].

  7. De la Cruz A, Fayad JN. Detection and management of childhood cholesteatoma. Pediatr Ann. Jun 1999;28(6):370-3. [Medline].

  8. Dornhoffer JL, Colvin GB, North P. Evidence of residual disease in ossicles of patients undergoing cholesteatoma removal. Acta Otolaryngol. Jan 1999;119(1):89-92. [Medline].

  9. Busaba NY. Clinical presentation and management of labyrinthine fistula caused by chronic otitis media. Ann Otol Rhinol Laryngol. May 1999;108(5):435-9. [Medline].

  10. Anderson J, Caye-Thomasen P, Tos M. A comparison of cartilage palisades and fascia in tympanoplasty after surgery for sinus or tensa retraction cholesteatoma in children. Otol Neurotol. Nov 2004;25(6):856-63. [Medline].

  11. Bennett M, Warren F, Jackson GC, Kaylie D. Congenital cholesteatoma: theories, facts, and 53 patients. Otolaryngol Clin North Am. Dec 2006;39(6):1081-94. [Medline].

  12. Chadha NK, Jardine A, Owens D, et al. A multivariate analysis of the factors predicting hearing outcome after surgery for cholesteatoma in children. J Laryngol Otol. Nov 2006;120(11):908-13. [Medline].

  13. Golz A, Goldenberg D, Netzer A, et al. Cholesteatomas associated with ventilation tube insertion. Arch Otolaryngol Head Neck Surg. Jul 1999;125(7):754-7. [Medline].

  14. Kemppainen HO, Puhakka HJ, Laippala PJ, et al. Epidemiology and aetiology of middle ear cholesteatoma. Acta Otolaryngol. 1999;119(5):568-72. [Medline].

  15. Migirov L, Duvdevani S, Kronenberg J. Otogenic intracranial complications: a review of 28 cases. Acta Otolaryngol. Aug 2005;125(8):819-22. [Medline].

  16. Ottaviani F, Neglia CB, Berti E. Cytokines and adhesion molecules in middle ear cholesteatoma. A role in epithelial growth?. Acta Otolaryngol. 1999;119(4):462-7. [Medline].

  17. Semaan MT, Megerian CA. The pathophysiology of cholesteatoma. Otolaryngol Clin North Am. Dec 2006;39(6):1143-59. [Medline].

  18. Thompson JW. Cholesteatomas. Pediatr Rev. Apr 1999;20(4):134-6. [Medline].

  19. Tierney PA, Pracy P, Blaney SP, Bowdler DA. An assessment of the value of the preoperative computed tomography scans prior to otoendoscopic 'second look' in intact canal wall mastoid surgery. Clin Otolaryngol Allied Sci. Aug 1999;24(4):274-6. [Medline].

Previous
Next
 
A typical audiogram demonstrating bilateral conductive hearing loss, which may be observed in an individual with a cholesteatoma.
The photo exhibits a large meatoplasty performed as part of an open cavity (canal wall down) mastoidectomy. A similar meatoplasty usually is necessary if a clean, dry, problem-free cavity is to be maintained.
An unenhanced CT scan demonstrating that the posterior canal wall has been eroded and the external auditory canal has filled with cholesteatoma, pus, and debris. Surprisingly, the middle ear appears relatively free of disease, a characteristic of primary acquired cholesteatomas.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.